ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 126 filers reported holding ANAPTYSBIO INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,948,897 | -44.6% | 341,637 | -40.7% | 0.16% | -44.8% |
| Q1 2023 | $12,546,816 | -29.8% | 576,600 | 0.0% | 0.30% | -30.5% |
| Q4 2022 | $17,868,834 | +21.5% | 576,600 | 0.0% | 0.43% | +13.2% |
| Q3 2022 | $14,709,000 | +26.6% | 576,600 | +0.8% | 0.38% | +12.4% |
| Q2 2022 | $11,618,000 | -16.6% | 572,300 | +1.6% | 0.34% | -3.7% |
| Q1 2022 | $13,936,000 | -25.6% | 563,300 | +4.6% | 0.35% | -18.9% |
| Q4 2021 | $18,720,000 | +28.8% | 538,700 | +0.5% | 0.43% | +41.5% |
| Q3 2021 | $14,532,000 | +4.7% | 535,832 | +0.1% | 0.31% | +11.7% |
| Q2 2021 | $13,879,000 | +20.3% | 535,232 | 0.0% | 0.27% | +8.7% |
| Q1 2021 | $11,534,000 | +73.4% | 535,232 | +73.0% | 0.25% | +78.7% |
| Q4 2020 | $6,652,000 | +45.9% | 309,413 | +0.1% | 0.14% | +21.6% |
| Q3 2020 | $4,559,000 | -33.5% | 309,113 | +0.8% | 0.12% | -38.3% |
| Q2 2020 | $6,852,000 | +61.6% | 306,713 | +2.2% | 0.19% | +7.4% |
| Q1 2020 | $4,239,000 | +93.2% | 300,000 | +122.2% | 0.18% | +153.6% |
| Q4 2019 | $2,194,000 | -73.9% | 135,000 | -43.8% | 0.07% | -79.4% |
| Q3 2019 | $8,398,000 | -31.9% | 240,000 | +9.8% | 0.34% | -24.9% |
| Q2 2019 | $12,328,000 | -0.7% | 218,500 | +28.5% | 0.45% | -6.9% |
| Q1 2019 | $12,419,000 | +43.2% | 170,000 | +25.0% | 0.48% | +17.1% |
| Q4 2018 | $8,675,000 | -47.3% | 136,000 | -17.6% | 0.41% | -31.4% |
| Q3 2018 | $16,462,000 | +54.5% | 165,000 | +10.0% | 0.60% | +45.4% |
| Q2 2018 | $10,656,000 | -24.2% | 150,000 | +11.1% | 0.41% | -31.6% |
| Q1 2018 | $14,051,000 | -2.0% | 135,000 | -5.2% | 0.60% | -8.0% |
| Q4 2017 | $14,343,000 | +173.6% | 142,400 | -5.1% | 0.65% | +169.0% |
| Q3 2017 | $5,243,000 | – | 150,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |